February 21, 2025 — Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli is the first FDA-approved drug to treat CTX, a very rare lipid storage…Original Article
FDA Approves Ctexli (chenodiol) for Cerebrotendinous Xanthomatosis
